article thumbnail

Confident Learned Intermediaries Defeat Warning Causation

Drug & Device Law

They’re experienced at what they do and aren’t intimidated by plaintiffs’ counsel and their threats of malpractice claims if they don’t testify the way plaintiffs want them to. Further, “both doctors testified that they still prescribe [the drug] for patients with conditions similar to plaintiff’s condition.” Schering Corp. ,

FDA 59
article thumbnail

Removal, Severance & Rule 21

Drug & Device Law

That started us thinking about other uses of severance of non-indispensable parties to preserve diversity – particularly, as in the Rejuvenate case, medical malpractice defendants in product liability litigation – to preserve federal diversity jurisdiction. We most recently returned to this issue here , where we discussed Sullivan v.